Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index T

Tachycardia: Sec. 3, Ch. 47
bradycardia with: Sec. 3, Ch. 47
ventricular: Sec. 3, Ch. 47
Tags
skin: Sec. 3 Ch. 35 [sidebar]
Tai chi: Sec. 3, Ch. 60; Sec. 1 Ch. 1 [sidebar]
Tamoxifen
blood clots with: Sec. 3, Ch. 49
in breast cancer: Sec. 3, Ch. 51
Tamsulosin
in benign prostatic hyperplasia: Sec. 3, Ch. 59
in prostatitis: Sec. 3, Ch. 59
urinary incontinence with: Sec. 3, Ch. 57
Tap water enema: Sec. 3, Ch. 55
Tardive dyskinesia: Sec. 3, Ch. 30; Sec. 3, Ch. 32
Tartar: Sec. 3, Ch. 39
Taste
aging-related changes in: Sec. 1, Ch. 2
Tea
urinary incontinence with: Sec. 3, Ch. 57
Team health care: Sec. 2, Ch. 9
during hospitalization: Sec. 2, Ch. 11
Tears: Sec. 3, Ch. 36
production of: Sec. 1, Ch. 2
Telmisartan
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
Telomeres: Sec. 1, Ch. 1
Temazepam: Sec. 2, Ch. 6; Sec. 3, Ch. 32
Temperature
body: Sec. 3, Ch. 19
     during surgery: Sec. 2, Ch. 12
     high (fever): Sec. 3, Ch. 19
     increase in (hyperthermia): Sec. 3, Ch. 19
     low (hypothermia): Sec. 3, Ch. 19
home: Sec. 3, Ch. 19; Sec. 3, Ch. 19
Temporal arteritis: Sec. 3, Ch. 36; Sec. 3, Ch. 36; Sec. 3, Ch. 42
blood clots with: Sec. 3, Ch. 49
Temporal artery
biopsy of: Sec. 3, Ch. 42; Sec. 3, Ch. 42
Temporal vein: Sec. 3, Ch. 44
Tendinitis
Achilles: Sec. 3, Ch. 40
Tenecteplase: Sec. 3, Ch. 45
TENS (transcutaneous electrical nerve stimulation): Sec. 2, Ch. 13; Sec. 3, Ch. 24
Terazosin
in benign prostatic hyperplasia: Sec. 3, Ch. 59
in high blood pressure: Sec. 3, Ch. 43
in prostatitis: Sec. 3, Ch. 59
urinary incontinence with: Sec. 3, Ch. 57
Teriparatide: Sec. 3, Ch. 22; Sec. 3, Ch. 22
Terminal illness: (see also End-of-life care)
hospice care for: 884-885
Test(s): Sec. 2, Ch. 10
biopsy: Sec. 2, Ch. 10
blood sugar (glucose): Sec. 3, Ch. 34
blood
     in thrombocythemia: Sec. 3, Ch. 49
body fluids: Sec. 2, Ch. 10
body function: Sec. 2, Ch. 10
bone density: Sec. 3, Ch. 22; Sec. 2, Ch. 4; Sec. 2, Ch. 10
diagnostic: Sec. 2, Ch. 10
endoscopic: Sec. 2, Ch. 10
genetic: Sec. 2, Ch. 10
hearing: Sec. 3, Ch. 37
imaging: Sec. 2, Ch. 10
mental status: Sec. 3, Ch. 25
Pap: Sec. 3, Ch. 58
preparation for: Sec. 2, Ch. 10
recommendation for: Sec. 2, Ch. 10
screening: (see Screening tests)
stress: Sec. 3, Ch. 45; Sec. 3, Ch. 47; Sec. 3, Ch. 47
before surgery: Sec. 2, Ch. 12
thyroid function: Sec. 3, Ch. 33; Sec. 3, Ch. 33
in undernutrition: Sec. 3, Ch. 17
urine: Sec. 3, Ch. 56
urodynamic
     in pelvic support disorders: Sec. 3, Ch. 58
Testes
aging of: Sec. 1, Ch. 1; Sec. 1, Ch. 2
Testosterone
aging-related changes in: Sec. 1, Ch. 2; Sec. 3, Ch. 17
bone maintenance and: Sec. 3 Ch. 22 [detail]
deficiency of
     erectile dysfunction and: Sec. 3 Ch. 59 [detail]
in osteoporosis: Sec. 3, Ch. 22
postmenopausal levels of: Sec. 3, Ch. 58
in prostate cancer: Sec. 3, Ch. 51
Thalamic stimulation: Sec. 3, Ch. 30
Thalamotomy: Sec. 3, Ch. 30
Thalidomide: Sec. 3, Ch. 51
Theophylline
in COPD: Sec. 3, Ch. 53
St. John's wort interaction with: Sec. 2, Ch. 7
undernutrition and: Sec. 3 Ch. 17 [detail]
Therapist: Sec. 2, Ch. 9
Thiazide
in heart failure: Sec. 3, Ch. 46
urinary incontinence with: Sec. 3, Ch. 57
Thiazolidinediones: Sec. 3, Ch. 34; Sec. 3, Ch. 34
Thioridazine: Sec. 2, Ch. 6; Sec. 3, Ch. 32
urinary incontinence with: Sec. 3, Ch. 57
Thiothixene: Sec. 2, Ch. 6; Sec. 3, Ch. 32
urinary incontinence with: Sec. 3, Ch. 57
Thirst
aging-related effects on: Sec. 3 Ch. 19 [detail]
in diabetes: Sec. 3, Ch. 34
in dying person: Sec. 2, Ch. 16
Three-dimensional conformal radiotherapy
in prostate cancer: Sec. 3, Ch. 51
Throat: Sec. 3, Ch. 38
in gastroesophageal reflux: Sec. 3, Ch. 54
sore: Sec. 3, Ch. 52
strep: Sec. 3, Ch. 48; Sec. 3, Ch. 48
tickle in: Sec. 3, Ch. 38
Thrombocytes: (see Platelet[s])
Thrombocythemia: Sec. 3, Ch. 49
primary: Sec. 3 Ch. 49 [sidebar]
Thrombocytopenia: Sec. 3, Ch. 49; Sec. 3, Ch. 49
Thrombocytopenic purpura
idiopathic: Sec. 3, Ch. 49; Sec. 3, Ch. 49
thrombotic: Sec. 3, Ch. 49
Thrombolytic drugs
in clotting disorders: Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]
in coronary artery disease: Sec. 3, Ch. 45
in deep vein thrombosis: Sec. 3, Ch. 44
in heart attack: Sec. 3, Ch. 45
in peripheral arterial disease: Sec. 3, Ch. 44
Thrombophlebitis
deep vein: Sec. 3, Ch. 44
migratory: Sec. 3, Ch. 44
superficial: Sec. 3, Ch. 44; Sec. 3, Ch. 49
Thrombosis: (see Blood clots)
deep vein: Sec. 3, Ch. 44
Thrombus: (see Blood clots)
Thrush: Sec. 3, Ch. 39
Thyroid disorders: Sec. 3, Ch. 33
dizziness in: Sec. 3, Ch. 20; Sec. 3, Ch. 20
high calcium level in: Sec. 3, Ch. 18
with high thyroid hormone level (hyperthyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 47
information resources on: 886
low calcium level in: Sec. 3, Ch. 18
with low thyroid hormone level (hypothyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 47
nodules in: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
Thyroid gland: Sec. 3, Ch. 33
cancer of: Sec. 3, Ch. 33; Sec. 3, Ch. 33
disorders of: (see Thyroid disorders)
enlargement of (goiter): Sec. 3, Ch. 33
information resources on: 886
nodules of: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
overactive (hyperthyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 47
underactive (hypothyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 47
Thyroid hormones: Sec. 3, Ch. 33
drug interactions with: Sec. 3, Ch. 33
high level of (hyperthyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 47
information resources on: 886
low level of (hypothyroidism): Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 47
replacement of: Sec. 3, Ch. 33
Thyroid scan
in hyperthyroidism: Sec. 3, Ch. 33
in nodule evaluation: Sec. 3, Ch. 33
Thyroid storm: Sec. 3, Ch. 33
Thyroid-stimulating hormone: Sec. 3 Ch. 33 [detail]
in hyperthyroidism: Sec. 3, Ch. 33
in hypothyroidism: Sec. 3, Ch. 33
Thyroiditis
Hashimoto's: Sec. 3, Ch. 33
Thyroxine
undernutrition and: Sec. 3 Ch. 17 [detail]
TIA (transient ischemic attack): Sec. 3, Ch. 28
Tic douloureux: Sec. 3, Ch. 29
Ticlopidine
in coronary artery disease: Sec. 3, Ch. 45
in peripheral arterial disease: Sec. 3, Ch. 44
Tilt table: Sec. 2, Ch. 13; Sec. 3, Ch. 20
Timolol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
Tinnitus: Sec. 3, Ch. 37
Tinzaparin: Sec. 3, Ch. 45
Tirofiban: Sec. 3 Ch. 49 [sidebar]
in coronary artery disease: Sec. 3, Ch. 45
Tissue plasminogen activator (tPA): Sec. 3 Ch. 49 [sidebar]
in coronary artery disease: Sec. 3, Ch. 45
in deep vein thrombosis: Sec. 3, Ch. 44
in peripheral arterial disease: Sec. 3, Ch. 44
in stroke: Sec. 3, Ch. 28
Tocainide: Sec. 3, Ch. 47
Toe raises: Sec. 3, Ch. 31
Toe(s)
corns of: Sec. 3, Ch. 40
hammer: Sec. 3, Ch. 40
Toenails
care of: Sec. 3 Ch. 40 [sidebar]
curling of: Sec. 3, Ch. 40
fungal infection of: Sec. 3, Ch. 40
thickening of: Sec. 3, Ch. 40
trimming of: Sec. 3, Ch. 40
Tolazamide: Sec. 3, Ch. 34
Tolbutamide: Sec. 3, Ch. 34
Tolcapone: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Tolterodine: Sec. 3, Ch. 57
Tongue
taste buds of: Sec. 1, Ch. 2
Tooth (teeth)
care for: Sec. 3, Ch. 39; Sec. 3, Ch. 39; Sec. 3, Ch. 39
cavities in: Sec. 3, Ch. 39
inflammation of: Sec. 3, Ch. 39
loss of: Sec. 3, Ch. 39
after cancer treatment: Sec. 3, Ch. 51
undernutrition and: Sec. 3 Ch. 17 [detail]
replacement of: Sec. 3, Ch. 39
Tophi: Sec. 3, Ch. 41; Sec. 3, Ch. 41
Torsemide: Sec. 3, Ch. 46; Sec. 3, Ch. 46
Torticollis
spasmodic: Sec. 3, Ch. 30
Toxic multinodular goiter: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
tPA (tissue plasminogen activator)
in stroke: Sec. 3, Ch. 28
tPA: (see Tissue plasminogen activator)
Trachea: Sec. 3, Ch. 38
Tracheitis: Sec. 3, Ch. 52
Traction
during rehabilitation: Sec. 2, Ch. 13
for fracture: Sec. 3, Ch. 23
Traffic violations: Sec. 4, Ch. 62
Trandolapril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Trans fatty acids: Sec. 2, Ch. 5; Sec. 2, Ch. 5
Transcutaneous electrical nerve stimulation (TENS): Sec. 2, Ch. 13; Sec. 3, Ch. 24
Transducer
for ultrasound scan: Sec. 2, Ch. 10
Transesophageal echocardiography
in aortic aneurysm: Sec. 3, Ch. 44
in aortic dissection: Sec. 3, Ch. 44
in heart valve disorders: Sec. 3, Ch. 48
in stroke evaluation: Sec. 3, Ch. 28
Transfer board: Sec. 2, Ch. 13
Transfer training: Sec. 2, Ch. 13
Transient ischemic attack (TIA): Sec. 3, Ch. 28
driving and: Sec. 4, Ch. 62
Translator: Sec. 2, Ch. 11
Transplantation
stem cell
     in chronic lymphocytic leukemia: Sec. 3, Ch. 51
     in multiple myeloma: Sec. 3, Ch. 51
     in myelofibrosis: Sec. 3, Ch. 49
Transurethral resection of prostate gland (TURP)
in benign prostatic hyperplasia: Sec. 3, Ch. 59
erectile dysfunction and: Sec. 3 Ch. 59 [detail]
Transverse myelitis: Sec. 3, Ch. 52; Sec. 3, Ch. 52
Trastuzumab: Sec. 3, Ch. 51
Travel
information resources on: 889
Trazodone
in depression: Sec. 3, Ch. 32
in insomnia: Sec. 3, Ch. 31
Tremor
essential: Sec. 3, Ch. 30
flapping: Sec. 3, Ch. 30
in Parkinson's disease: Sec. 3, Ch. 30
of voice: Sec. 3, Ch. 38
Triamcinolone: Sec. 3, Ch. 41
Triamterene: Sec. 3, Ch. 18
Tricuspid valve: Sec. 3, Ch. 45; Sec. 3, Ch. 48
Tricyclic antidepressants
in depression: Sec. 3, Ch. 32
movement disorder with: Sec. 3, Ch. 30
Trifluoperazine: Sec. 3, Ch. 32
Trigeminal neuralgia: Sec. 3, Ch. 29
Triglycerides
in coronary artery disease: Sec. 3, Ch. 45
desirable level of: Sec. 3, Ch. 44
disease-related abnormalities in: Sec. 3, Ch. 44
stroke and: Sec. 3 Ch. 28 [detail]
Trihexyphenidyl
in dystonia: Sec. 3, Ch. 30
in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Trimethobenzamide: Sec. 2, Ch. 6
Tripelennamine: Sec. 2, Ch. 6
Troponin: Sec. 3, Ch. 45
Tube
feeding: Sec. 2, Ch. 11
     after surgery: Sec. 2, Ch. 12
     in undernutrition: Sec. 3, Ch. 17
Tuberculosis: Sec. 1, Ch. 2
Tumor necrosis factor inhibitors: Sec. 3, Ch. 41
Tumor necrosis factor: Sec. 3, Ch. 50
Tumor(s): Sec. 3, Ch. 50 (see also Cancer)
benign: Sec. 3, Ch. 50
breast: (see also Breasts, cancer of)
head: Sec. 3, Ch. 51
information resources on: 883-884
large intestine: (see also Large intestine, cancer of)
lung: Sec. 3, Ch. 51
mouth: Sec. 3, Ch. 51
neck: Sec. 3, Ch. 51
prostate: Sec. 3, Ch. 51 (see also Prostate gland, cancer of)
screening for: (see Screening tests, for cancer)
skin: Sec. 3, Ch. 51
vulva: Sec. 3, Ch. 51
Tuning fork test: Sec. 3, Ch. 37
TURP (transurethral resection of prostate gland): Sec. 3, Ch. 59
erectile dysfunction and: Sec. 3 Ch. 59 [detail]
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.